Nicotine

Manufacturer
Wal-Mart Stores Inc
Effective date
2026-01-26
Label type
HUMAN OTC DRUG LABEL
Version
15
Source
full-release
Hydrated at
2026-06-01 01:35:05

Label at a glance#

ProductNicotine transdermal system
Active ingredientNICOTINE
Label structure14 sections

Dosage and administration

• if you are under 18 years of age, ask a doctor before use • before using this product, read the enclosed User’s Guide for complete directions and other information • begin using the patch on your quit day • if you smoke more than 10 cigarettes per day, use according to the following 10 week schedule: STEP 1 STEP 2 STEP 3 Use one 21 mg patch/day Use one 14 mg patch/day Use one 7 mg patch/day Weeks 1-6 Weeks 7-8 W...

Label contents#

Full prescribing information#

Active ingredient Step 1 (in each patch)

OTC - ACTIVE INGREDIENT SECTION

Nicotine, 21 mg delivered over 24 hours

Active ingredient Step 2 (in each patch)

OTC - ACTIVE INGREDIENT SECTION

Nicotine, 14 mg delivered over 24 hours

Active ingredient Step 3 (in each patch)

OTC - ACTIVE INGREDIENT SECTION

Nicotine, 7 mg delivered over 24 hours

Purpose

OTC - PURPOSE SECTION

Stop smoking aid

Use

INDICATIONS & USAGE SECTION

reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Warnings

WARNINGS SECTION

If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider.

OTC - PREGNANCY OR BREAST FEEDING SECTION

Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.
  • high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
  • an allergy to adhesive tape or have skin problems because you are more likely to get rashes
  • stomach ulcers or diabetes
  • history of seizures

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

  • using a non-nicotine stop smoking drug
  • taking a prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.

When using this product

OTC - WHEN USING SECTION

  • if you have vivid dreams or other sleep disturbances remove this patch at bedtime

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • skin redness caused by the patch does not go away after four days, or if your skin swells, or you get a rash
  • irregular heartbeat or palpitations occur
  • you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, weakness and rapid heartbeat
  • you have symptoms of an allergic reaction (such as difficulty breathing or rash)

Keep out of reach of children and pets.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Used patches have enough nicotine to poison children and pets. If swallowed, get medical help or contact a Poison Control Center right away. Dispose of the used patches by folding sticky ends together. Replace in pouch and discard.

Directions

DOSAGE & ADMINISTRATION SECTION

  • if you are under 18 years of age, ask a doctor before use
  • before using this product, read the enclosed User’s Guide for complete directions and other information
  • begin using the patch on your quit day
  • if you smoke more than 10 cigarettes per day, use according to the following 10 week schedule:

STEP 1

STEP 2

STEP 3

Use one 21 mg patch/day

Use one 14 mg patch/day

Use one 7 mg patch/day

Weeks 1-6

Weeks 7-8

Weeks 9-10

  • if you smoke 10 or less cigarettes per day, do not use STEP 1 (21 mg). Start with STEP 2 (14 mg) for 6 weeks, then STEP 3 (7 mg) for 2 weeks and then stop.
  • steps 2 and 3 allow you to gradually reduce your level of nicotine. Completing the full program will increase your chances of quitting successfully.
  • apply one new patch every 24 hours on skin that is dry, clean and hairless. Save pouch for disposing of the patch after use.
  • remove backing from patch and immediately press onto skin. Hold for 10 seconds.
  • wash hands after applying or removing patch. Throw away the patch by folding sticky ends together. Replace in its pouch and discard. See enclosed User’s Guide for safety and handling.
  • you may wear the patch for 16 or 24 hours.
  • if you crave cigarettes when you wake up, wear the patch for 24 hours.
  • if you have vivid dreams or other sleep disturbances, you may remove the patch at bedtime and apply a new one in the morning
  • the used patch should be removed and a new one applied to a different skin site at the same time each day
  • do not wear more than one patch at a time
  • do not cut patch in half or into smaller pieces
  • do not leave patch on for more than 24 hours because it may irritate your skin and loses strength after 24 hours
  • it is important to complete treatment. If you feel you need to use the patch for a longer period to keep from smoking, talk to your healthcare provider.

Other information

SPL UNCLASSIFIED SECTION

store at 20 – 25oC (68 – 77oF)

Inactive ingredients

INACTIVE INGREDIENT SECTION

ethylene vinyl acetate-copolymer, polyisobutylene and high density polyethylene between clear polyester backings

Questions or comments?

OTC - QUESTIONS SECTION

call 1-888-287-1915

Generic Section

SPL UNCLASSIFIED SECTION

Read carton and enclosed User’s Guide before using this product. Keep this carton and User’s Guide. They contain important information.

Includes User’s Guide with behavioral support program enrollment offer.

To increase your success in quitting:

  1. You must be motivated to quit.
  2. Complete the full treatment program, applying a new patch every day.
  3. Use with a support program as described in the enclosed User’s Guide.

For your family’s protection, nicotine patches are supplied in child-resistant pouches. Do not use if individual pouch is open or torn.

What is the nicotine patch and how is it used?

The nicotine patch is a small, nicotine-containing patch. When you put on a nicotine patch, nicotine passes through the skin and into your body. The nicotine patch is very thin and uses special material to control how fast nicotine passes through the skin. Unlike the sudden jolts of nicotine delivered by cigarettes, the amount of nicotine you receive remains relatively smooth throughout the 16 or 24 hour period you wear the nicotine patch. This helps to reduce cravings you may have for nicotine.

READ THE LABEL

  • Not for sale to those under 18 years of age.
  • Proof of age required.
  • Not for sale in vending machines or from any source where proof of age cannot be verified.

Satisfaction guaranteed – Or we’ll replace it or give you your money back. For questions or comments or to report an undesired reaction or side effect, please call 1-888-287-1915.

DISTRIBUTED BY: Walmart Inc.

Bentonville, AR 72716

PRODUCT OF IRELAND

*NICODERM and CQ are trademarks owned by or licensed to the GSK group of companies.

PRINCIPAL DISPLAY PANEL (21 mg, 14 patches)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 49035-194-02

equate

Compare to NicoDerm® CQ® active ingredient*

CLEAR

Nicotine Transdermal System

21 mg Delivered Over 24 Hours

Stop Smoking Aid

STEP 1

21 mg

14 PATCHES

(2-week Kit)

If you smoke more than 10 cigarettes per day, start with Step 1

If you smoke 10 or less cigarettes per day, start with Step 2

The full course of treatment for STEP 1 is 42 patches (6 weeks); this package contains 14 patches (2-week course) only. Read the enclosed User’s Guide for additional information.

14 CLEAR PATCHES (2-WEEK KIT)

Equate Nicotine Patch 21 mg 14 ct
Equate Nicotine Patch 21 mg 14 ct

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

 NDC 49035-195-02

equate

Compare to NicoDerm® CQ® active ingredient*

CLEAR

Nicotine Transdermal System

14 mg Delivered Over 24 Hours

Stop Smoking Aid

STEP 2

14 mg

14 PATCHES

(2-week Kit)

If you smoke more than 10 cigarettes per day, start with Step 1

If you smoke 10 or less cigarettes per day, start with Step 2

The full course of treatment for STEP 2 is 2 or 6 weeks (depending on how many cigarettes you smoke per day). Read the enclosed User’s Guide for additional information.

14 CLEAR PATCHES (2-WEEK KIT)

Equate Nicotine Patch 14 mg 14 ct
Equate Nicotine Patch 14 mg 14 ct

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

 NDC 49035-196-02

equate

Compare to NicoDerm® CQ® active ingredient*

CLEAR

Nicotine Transdermal System

7 mg Delivered Over 24 Hours

Stop Smoking Aid

STEP 3

7 mg

14 PATCHES

(2-week Kit)

For use after completing Step 2

14 CLEAR PATCHES (2-WEEK KIT)

Equate Nicotine Patch 7 mg 14 ct
Equate Nicotine Patch 7 mg 14 ct

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
198029nicotine 14 MG/Day 24HR Transdermal SystemPSN15
198030nicotine 21 MG/Day 24HR Transdermal SystemPSN15
198031nicotine 7 MG/Day 24HR Transdermal SystemPSN15
19803124 HR nicotine 0.292 MG/HR Transdermal SystemSCD15
19802924 HR nicotine 0.583 MG/HR Transdermal SystemSCD15
19803024 HR nicotine 0.875 MG/HR Transdermal SystemSCD15
198031nicotine 0.292 MG/HR 24HR Transdermal PatchSY15
198029nicotine 0.583 MG/HR 24HR Transdermal PatchSY15
198030nicotine 0.875 MG/HR 24HR Transdermal PatchSY15
198029nicotine 14 MG per 24HR 1 Day Transdermal PatchSY15
198029nicotine 14 MG/Day 24HR Transdermal SystemSY15
198030nicotine 21 MG per 24HR 1 Day Transdermal PatchSY15
198030nicotine 21 MG/Day 24HR Transdermal SystemSY15
198031nicotine 7 MG per 24HR 1 Day Transdermal PatchSY15
198031nicotine 7 MG/Day 24HR Transdermal SystemSY15

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
NICOTINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dbebfdf8-6e0c-cfa8-fdbc-e5d7f1bf1562Product name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49035-194-01Nicotinetransdermal system7 in 1 CARTONPATCH, EXTENDED RELEASE715
49035-194-01Nicotinetransdermal system24 h in 1 PATCHPATCH, EXTENDED RELEASE2415
49035-194-02Nicotinetransdermal system14 in 1 CARTONPATCH, EXTENDED RELEASE1415
49035-194-02Nicotinetransdermal system24 h in 1 PATCHPATCH, EXTENDED RELEASE2415
49035-195-02Nicotinetransdermal system14 in 1 CARTONPATCH, EXTENDED RELEASE1415
49035-195-02Nicotinetransdermal system24 h in 1 PATCHPATCH, EXTENDED RELEASE2415
49035-196-02Nicotinetransdermal system24 h in 1 PATCHPATCH, EXTENDED RELEASE2415
49035-196-02Nicotinetransdermal system14 in 1 CARTONPATCH, EXTENDED RELEASE1415

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
49035-194-01EA - Each49035-1941822c446-eb6a-4fa5-9fc3-4e2f2b4b498212013-02-13
49035-194-02EA - Each49035-19411f4038f-fa4d-41d3-aa07-6d0ec0a4f27a12013-02-13
49035-195-02EA - Each49035-1958f181161-0a70-4fea-ab7e-6fe817372d1e12013-07-02
49035-196-02EA - Each49035-196c3971351-58ce-4e09-b076-99bd1f0b139e12015-03-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
NICOTINEACTIVE INGREDIENT6M3C89ZY6R6
NICOTINEACTIVE MOIETY6M3C89ZY6R6
ETHYLENE-VINYL ACETATE COPOLYMER (40% VINYL ACETATE)INACTIVE INGREDIENTL5F16ZG4ZU6
HIGH DENSITY POLYETHYLENEINACTIVE INGREDIENTUG00KM4WR76

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49035-19449035-194-02, 49035-194-01
49035-19549035-195-02
49035-19649035-196-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 14 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7SYSTEM / TRANSDERMALNAExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7FILM, EXTENDED RELEASE / TRANSDERMAL85 mgExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7SYSTEM / TRANSDERMALNAExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7SYSTEM / TRANSDERMALNAExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7FILM, EXTENDED RELEASE / TRANSDERMAL85 mgExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7FILM, EXTENDED RELEASE / TRANSDERMAL85 mgExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7FILM, EXTENDED RELEASE / TRANSDERMAL85 mgExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7SYSTEM / TRANSDERMALNAExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7SYSTEM / TRANSDERMALNAExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7FILM, EXTENDED RELEASE / TRANSDERMAL85 mgExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7FILM, EXTENDED RELEASE / TRANSDERMAL85 mgExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7FILM, EXTENDED RELEASE / TRANSDERMAL85 mgExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7SYSTEM / TRANSDERMALNAExact identifier — unii+route
14 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7SYSTEM / TRANSDERMALNAExact identifier — unii+route
14 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020165-004NICODERM CQNICOTINE21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-02
N020165-005NICODERM CQNICOTINE14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02
N020165-006NICODERM CQNICOTINE7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-0284e616aacf4f…
2026-09-14 22:38:342026-08N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-0284e616aacf4f…
2026-09-14 22:38:342026-08N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-0284e616aacf4f…
2026-08-18 06:07:402026-07N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-02caaa826d4ba7…
2026-08-18 06:07:402026-07N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02caaa826d4ba7…
2026-08-18 06:07:402026-07N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-02011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-0231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-0231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-0231067a03dcf5…
2025-08-23 18:47 UTC2025-08N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-026a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-026a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-026a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-02fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-02b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-0203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-0203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-0203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-022680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-022680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-022680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-025bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-025bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-025bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-02d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-02d06236e962d9…
2024-10-29 15:01 UTC2024-10N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02d06236e962d9…
2024-10-29 15:01 UTC2024-10N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-02d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-0279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020165-005NICODERM CQ14MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-0279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020165-006NICODERM CQ7MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD1996-08-0279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020165-004NICODERM CQ21MG/24HRFILM, EXTENDED RELEASE / TRANSDERMALRLD, RS1996-08-02301d65b070ca…

Observed Orange Book patent history#

Patent history page 1 of 2 · 75 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2019-12-13 00:20 UTC2019-12N020165-00492050592019-12-15Drug product2016-01-0674a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00486636802020-02-13Drug product2014-03-3174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00489993792020-02-13U-16862015-05-0474a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00480759112021-05-22Drug product2012-03-0974a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00592050592019-12-15Drug product2016-01-0674a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00586636802020-02-13Drug product2014-03-3174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00589993792020-02-13U-16862015-05-0474a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00580759112021-05-22Drug product74a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00692050592019-12-15Drug product2016-01-0674a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00686636802020-02-13Drug product2014-03-3174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00689993792020-02-13U-16862015-05-0474a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020165-00680759112021-05-22Drug product74a2ff9319b5…
2021-12-28 21:50 UTC2021-12N020165-00480759112021-05-22Drug product2012-03-09782e0a99824c…
2021-12-28 21:50 UTC2021-12N020165-00580759112021-05-22Drug product782e0a99824c…
2021-12-28 21:50 UTC2021-12N020165-00680759112021-05-22Drug product782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020165-00480759112021-05-22Drug product2012-03-0987673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020165-00580759112021-05-22Drug product87673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020165-00680759112021-05-22Drug product87673890dc5c…
2021-03-12 10:30 UTC2021-03N020165-00480759112021-05-22Drug product2012-03-095aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N020165-00580759112021-05-22Drug product5aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N020165-00680759112021-05-22Drug product5aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020165-00486636802020-02-13Drug product2014-03-318869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020165-00489993792020-02-13U-16862015-05-048869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020165-00480759112021-05-22Drug product2012-03-098869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020165-00586636802020-02-13Drug product2014-03-318869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020165-00589993792020-02-13U-16862015-05-048869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020165-00580759112021-05-22Drug product8869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020165-00686636802020-02-13Drug product2014-03-318869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020165-00689993792020-02-13U-16862015-05-048869cabd3fbd…
2020-12-22 03:56 UTC2020-12N020165-00680759112021-05-22Drug product8869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020165-00486636802020-02-13Drug product2014-03-31c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020165-00489993792020-02-13U-16862015-05-04c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020165-00480759112021-05-22Drug product2012-03-09c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020165-00586636802020-02-13Drug product2014-03-31c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020165-00589993792020-02-13U-16862015-05-04c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020165-00580759112021-05-22Drug productc0c555d07b60…
2020-11-12 02:37 UTC2020-11N020165-00686636802020-02-13Drug product2014-03-31c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020165-00689993792020-02-13U-16862015-05-04c0c555d07b60…
2020-11-12 02:37 UTC2020-11N020165-00680759112021-05-22Drug productc0c555d07b60…
2019-12-14 00:12 UTC2019-12N020165-00492050592019-12-15Drug product2016-01-063f01610625f2…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Nicotine transdermal systemNICOTINEWal-Mart Stores Incaefd30c4-35d5-425e-855c-327a7c4361882026-01-26WarningsExact identifier
ndc (package): 49035-194-01
ndc (package): 49035-195-02
ndc (package): 49035-196-02
ndc (package): 49035-194-02
ndc (product): 49035-196
ndc (product): 49035-195
ndc (product): 49035-194
ndc11 (package): 49035019401
ndc11 (package): 49035019602
ndc11 (package): 49035019502
ndc11 (package): 49035019402
spl id: 085e5042-be1f-49ea-88a8-804fc969824f
spl set id: aefd30c4-35d5-425e-855c-327a7c436188

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.